[Mechanisms of resistance to beta lactams and nalidixic acid in clinical isolates of Salmonella enteritidis serotype Hadar and Bsilla]. - Suppr | 超能文献

[Mechanisms of resistance to beta lactams and nalidixic acid in clinical isolates of Salmonella enteritidis serotype Hadar and Bsilla].

作者信息

Ruiz Joaquim, Navia Margarita María, Marco Francesc, Vila Jordi

出版信息

Enferm Infecc Microbiol Clin. 2004 Apr;22(4):252-3. doi: 10.1016/s0213-005x(04)73078-5.

DOI:10.1016/s0213-005x(04)73078-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Mechanisms of resistance to beta lactams and nalidixic acid in clinical isolates of Salmonella enteritidis serotype Hadar and Bsilla].

Enferm Infecc Microbiol Clin. 2004 Apr;22(4):252-3. doi: 10.1016/s0213-005x(04)73078-5.

2

[Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].

Enferm Infecc Microbiol Clin. 2004 Apr;22(4):204-11. doi: 10.1016/s0213-005x(04)73067-0.

3

Trends in serotype distribution and antimicrobial susceptibility in Salmonella enterica isolates from humans in Belgium, 2009 to 2013.

Antimicrob Agents Chemother. 2015 Jan;59(1):544-52. doi: 10.1128/AAC.04203-14. Epub 2014 Nov 10.

4

Antimicrobial resistance in clinical isolates of Salmonella enterica serotype Enteritidis: relationships between mutations conferring quinolone resistance, integrons, plasmids and genetic types.

J Antimicrob Chemother. 2003 May;51(5):1287-91. doi: 10.1093/jac/dkg193. Epub 2003 Mar 28.

5

Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.

J Antimicrob Chemother. 2005 Dec;56(6):1111-4. doi: 10.1093/jac/dki369. Epub 2005 Oct 21.

6

Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.

Int J Antimicrob Agents. 2004 Sep;24(3):300-3. doi: 10.1016/j.ijantimicag.2004.02.029.

7

Prevalence and characterization of extended-spectrum beta-lactamases-producing Salmonella enterica isolates in Saragossa, Spain (2001-2008).

Microb Drug Resist. 2011 Jun;17(2):207-13. doi: 10.1089/mdr.2010.0105. Epub 2011 Jan 16.

8

Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.

J Clin Microbiol. 2015 Nov;53(11):3411-7. doi: 10.1128/JCM.01287-15. Epub 2015 Aug 19.

9

Emergence of extended-spectrum beta-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran.

Jpn J Infect Dis. 2009 Sep;62(5):368-71.

10

Multidrug-resistant Salmonella enterica serotype Senftenberg isolates producing CTX-M beta-lactamases from Constantine, Algeria.

J Antimicrob Chemother. 2005 Aug;56(2):439-40. doi: 10.1093/jac/dki216. Epub 2005 Jun 20.

引用本文的文献

1

Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones.

Life (Basel). 2024 Mar 14;14(3):383. doi: 10.3390/life14030383.